Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-0-387-72076-0_19
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease

  2007cited by this paper
• Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

  2004cited by this paper
• Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

  2004cited by this paper
• Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.

  2004cited by this paper
• Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture.

  2004cited by this paper
• Alzheimer's amyloid β-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide

  2004cited by this paper
• Alzheimer's disease: the two-hit hypothesis

  2004cited by this paper
• Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease

  2004cited by this paper
• Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?

  2003cited by this paper
• Proteomic identification of nitrated proteins in Alzheimer's disease brain

  2003cited by this paper
• Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease

  2003cited by this paper
• Sources contributing to the initiation and propagation of oxidative stress in Alzheimer disease

  2003cited by this paper
• Anti-AGEing defences against Alzheimer's disease.

  2003cited by this paper
• Increased p27, an essential component of cell cycle control, in Alzheimer's disease

  2003cited by this paper
• Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation

  2003cited by this paper
• Oxidative damage in the olfactory system in Alzheimer's disease

  2003cited by this paper
• The biological role of the Alzheimer amyloid precursor protein in epithelial cells

  2002cited by this paper
• Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.

  2002cited by this paper
• Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer’s APP mutation and sensitizes cells to staurosporine-induced cell death

  2002cited by this paper
• Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

  2002cited by this paper
• High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal*

  2002cited by this paper
• Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression.

  2002cited by this paper
• β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation

  2002cited by this paper
• The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain

  2002cited by this paper
• Cell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle

  2002cited by this paper
• Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration.

  2002cited by this paper
• Impaired cell cycle control of neuronal precursor cells in the neocortical primordium of presenilin‐1‐deficient mice

  2002cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation

  2001cited by this paper
• Do neurons have a choice in death?

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001cited by this paper
• DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease

  2001cited by this paper
• Increased 8,12‐iso‐iPF2α‐VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity

  2000cited by this paper
• Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes.

  2000cited by this paper
• Cyclin' toward dementia

  2000cited by this paper
• In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification

  2000cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000cited by this paper
• A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation.

  2000cited by this paper
• Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest.

  2000cited by this paper
• Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease.

  2000cited by this paper
• The Amyloid Precursor Protein-binding Protein APP-BP1 Drives the Cell Cycle through the S-M Checkpoint and Causes Apoptosis in Neurons*

  2000cited by this paper
• Apolipoprotein E allele–dependent antioxidant activity in brains with Alzheimer’s disease

  2000cited by this paper
• Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome

  2000cited by this paper
• Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.

  1999cited by this paper
• Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant.

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• Mitotic signaling by β‐amyloid causes neuronal death

  1999cited by this paper
• Traumatic brain injury in young, amyloid‐β peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Aβ deposition during aging

  1999cited by this paper
• Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis.

  1999cited by this paper
• Cell cycle events in neurons. Proliferation or death?

  1999cited by this paper
• Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease.

  1999cited by this paper
• Is oxidative damage central to the pathogenesis of Alzheimer disease?

  1998cited by this paper
• Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

  1998cited by this paper
• Increased F2‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo

  1998cited by this paper
• A suicide note from Alzheimer disease neurons?

  1998cited by this paper
• Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain

  1998cited by this paper
• Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease.

  1998cited by this paper
• The expression of key oxidative stress-handling genes in different brain regions in alzheimer’s disease

  1998cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• Early glycoxidation damage in brains from Down's syndrome.

  1998cited by this paper
• Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.

  1997cited by this paper
• Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

  1997cited by this paper
• Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions

  1997cited by this paper
• Amyloid, the presenilins and Alzheimer's disease.

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• The presenilins and Alzheimer's disease.

  1997cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper
• Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain

  1997cited by this paper
• Alzheimer's Disease--Genotypes, Phenotype, and Treatments

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• Cell cycle markers in the hippocampus in Alzheimer’s disease

  1997cited by this paper
• Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.

  1997cited by this paper
• Risk of Alzheimer's disease and duration of NSAID use

  1997cited by this paper
• Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

  1996cited by this paper
• E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.

  1996cited by this paper
• Evidence of neuronal oxidative damage in Alzheimer's disease.

  1996cited by this paper
• Trk receptor alterations in Alzheimer's disease.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

  1996cited by this paper
• Oxidative damage in Alzheimer's

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

  1996cited by this paper
• Evidence for oxidative stress in Pick disease and corticobasal degeneration.

  1995cited by this paper
• Ki‐67 Immunoreactivity in Alzheimer's Disease and Other Neurodegenerative Disorders

  1995cited by this paper
• Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

  1995cited by this paper
• Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease

  1995cited by this paper
• Transient adaptation of oxidative stress in mammalian cells.

  1995cited by this paper
• Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide

  1995cited by this paper
• Transient adaptation to oxidative stress in yeast.

  1995cited by this paper
• Apoptosis and the cell cycle

  1995cited by this paper
• Early AGEing and Alzheimer's

  1995cited by this paper
• Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

  1995cited by this paper
• Radical AGEing in Alzheimer's disease.

  1995cited by this paper
• Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

  1995cited by this paper
• Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

  1994cited by this paper
• A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

  1994cited by this paper

• NET amyloidogenic backbone in human activated neutrophils

  2016cites this paper
• The main actors involved in parasitization of Heliothis virescens larva

  2012influential citation
• NMR Studies of Zinc, Copper, and Iron Binding to Histidine, the Principal Metal Ion Complexing Site of Amyloid-β Peptide

  2010cites this paper
• Oxidative Stress in Diabetes and Alzheimer's Disease

  2009cites this paper